- Home
- ROIV vs XP Comparison
ROIV vs XP Comparison
Compare ROIV & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- XP
- Stock Information
- Founded
- ROIV 2014
- XP 2001
- Country
- ROIV United Kingdom
- XP Cayman Islands
- Employees
- ROIV N/A
- XP N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- ROIV Health Care
- XP Finance
- Exchange
- ROIV Nasdaq
- XP Nasdaq
- Market Cap
- ROIV 7.8B
- XP 10.6B
- IPO Year
- ROIV N/A
- XP 2019
- Fundamental
- Price
- ROIV $11.36
- XP $18.22
- Analyst Decision
- ROIV Buy
- XP Strong Buy
- Analyst Count
- ROIV 4
- XP 5
- Target Price
- ROIV $17.50
- XP $23.80
- AVG Volume (30 Days)
- ROIV 7.8M
- XP 5.0M
- Earning Date
- ROIV 08-07-2025
- XP 08-12-2025
- Dividend Yield
- ROIV N/A
- XP 7.58%
- EPS Growth
- ROIV N/A
- XP 15.23
- EPS
- ROIV N/A
- XP 1.51
- Revenue
- ROIV $29,053,000.00
- XP $2,886,046,386.00
- Revenue This Year
- ROIV $3.28
- XP $18.83
- Revenue Next Year
- ROIV $156.84
- XP $12.86
- P/E Ratio
- ROIV N/A
- XP $11.87
- Revenue Growth
- ROIV N/A
- XP 9.27
- 52 Week Low
- ROIV $8.73
- XP $10.82
- 52 Week High
- ROIV $13.06
- XP $20.64
- Technical
- Relative Strength Index (RSI)
- ROIV 52.70
- XP 38.62
- Support Level
- ROIV $10.71
- XP $17.91
- Resistance Level
- ROIV $11.58
- XP $19.97
- Average True Range (ATR)
- ROIV 0.31
- XP 0.39
- MACD
- ROIV 0.02
- XP -0.25
- Stochastic Oscillator
- ROIV 60.93
- XP 13.55
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.